CAAS Capital Management’s iHuman IH Stock Holding History

CAAS Capital Management’s Portfolio IH Stock Details IH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,000	Closed	-$181K	–	1269
2020 Q4	$181K	Buy	+10,000	New	+$223K	﹤0.01%	769

Other funds holding IH

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TAMH

Taikang Asset Management (HK) Hong Kong $1B AUM 27.37% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CAAS Capital Management's IH Position: Q1 2021 in Review

CAAS Capital Management sold out of iHuman (IH) in Q1 2021, closing a stake of 10,000 shares — an estimated $181K sold.

CAAS Capital Management first reported a position in IH in Q4 2020 and held it in 1 quarter. The position peaked at $181K in Q4 2020. 13 funds tracked by Wall St. Rank hold IH as of Q1 2021.

CAAS Capital Management reported no remaining iHuman position as of Q1 2021 after selling out during the quarter.
CAAS Capital Management sold 10,000 iHuman shares in Q1 2021, an estimated $181K.
CAAS Capital Management first reported a position in iHuman in Q4 2020 and held it in 1 quarter.
CAAS Capital Management's iHuman position peaked at $181K in Q4 2020.
13 funds tracked by Wall St. Rank held iHuman as of Q1 2021.

Based on CAAS Capital Management's 13F filing for Q1 2021, filed 17 May 2021.